Hosted by the award-winning editorial staff of Ophthalmology Times®, EyePod podcasts feature the latest updates and resources most relevant to professionals across the eyecare industry.
3: OT Roundup Ep. 3: Optogenetics Nobel Prize, remigromig in DME, Stargardt, eye transplant
This edition of OT Roundup covers the Nobel Prize in Physiology or Medicine for optogenetics and its link to MCO-010 in retinitis pigmentosa, BRUNELLO phase 2b/3 results for remigromig in diabetic macular edema (DME) with Veeral Sheth, MD, phase 3 DRAGON results for tinlarebant in Stargardt disease, and what the first total human eye transplant has taught surgeons.
6 Oct 2026
3: Beyond the Walls: Dry eye, downward dog, and doing medicine differently with Priya M. Mathews, MD, MPH
In this episode of the Ophthalmology Times® "Beyond the Walls" podcast, host Deborah Ristvedt, DO, sits down with Priya Mathews, MD, a cornea, cataract, and refractive surgeon, dry eye expert, and educator, to explore the experiences and passions that have shaped her career and her approach to patient care.
Mathews shares how a mentor sparked a lifelong commitment to dry eye care — a patient population she felt was historically underserved. She discusses building a dedicated dry eye rehab clinic, why treating the ocular surface is essential for premium cataract outcomes, and how her 15-year yoga practice has woven itself into her vision for whole-patient care. From navigating early career self-doubt to designing a practice built around purpose, Mathews offers an honest and inspiring look at what it means to follow your calling in medicine.
Check out more episodes of Beyond the Walls at https://www.ophthalmologytimes.com/podcasts/beyond-the-walls
(https://www.ophthalmologytimes.com/podcasts/beyond-the-walls)
#Ophthalmology #EyeCare #BeyondTheWalls #DryEye #OcularSurface #WomenInOphthalmology #Podcast #OphthalmologyTimes
2 Oct 2026
2: OT Roundup: MOGENRY data, RCA report, SYD-101, OCU410
Episode 2 of OT Roundup is here. Lucia Gambuzza and co-host Veeral Sheth, MD, break down 4-year durability data for MOGENRY in retinitis pigmentosa, RCA's first State of Retina Care report, the FDA's upcoming review of SYD-101 for pediatric myopia, and new Phase 2 data on OCU410 for geographic atrophy.
MOGENRY 4-year data: https://www.ophthalmologytimes.com/view/retina-society-2026-mco-010-optogenetic-therapy-maintains-visual-acuity-gains-through-4-years-in-advanced-rp
(https://www.ophthalmologytimes.com/view/retina-society-2026-mco-010-optogenetic-therapy-maintains-visual-acuity-gains-through-4-years-in-advanced-rp)
RCA's State of Retina Care report: https://www.ophthalmologytimes.com/view/rca-releases-first-state-of-retina-care-report
(https://www.ophthalmologytimes.com/view/rca-releases-first-state-of-retina-care-report)
FDA Advisory Committee on SYD-101: https://www.ophthalmologytimes.com/view/fda-advisory-committee-syd-101-pediatric-myopia-october-30
(https://www.ophthalmologytimes.com/view/fda-advisory-committee-syd-101-pediatric-myopia-october-30)
Nimesh Patel, MD on pediatric progressive myopia: https://www.ophthalmologytimes.com/view/pediatric-progressive-myopia-epidemic-permanent-vision-loss (https://www.ophthalmologytimes.com/view/nimesh-patel-md-on-low-dose-atropine-syd-101)
OCU410 Phase 2 data: https://www.ophthalmologytimes.com/view/retina-society-2026-medium-dose-ocu410-gene-therapy-cuts-geographic-atrophy-progression-up-to-32-in-phase-2-trial
(https://www.ophthalmologytimes.com/view/retina-society-2026-medium-dose-ocu410-gene-therapy-cuts-geographic-atrophy-progression-up-to-32-in-phase-2-trial)
Contact EyePod
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of EyePod?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
